SKI Market

Indian Indices

Nifty

25,044.35 72.45
(0.29%)

Sensex

82,055.11 158.32
( 0.19%)

Bank Nifty

56,461.90 402.55
( 0.72%)

Nifty IT

38,417.95 3.85
( 0.01%)

Global Indices

Nasdaq

42,601.30 373.47
(0.88%)

Dow Jones

6,045.90 57.06
(0.95%)

Hang Seng

38,777.68 423.59
(1.10%)

Nikkei 225

8,758.04 -16.61
(-0.19%)

Forex

USD-INR

86.50 -0.18
(-0.20%)

EUR-INR

99.61 0.16
(0.17%)

GBP-INR

116.27 -0.12
(-0.11%)

JPY-INR

0.59 0.00
(-0.73%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Cipla Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

500087

INE059A01026

397.4117939

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

CIPLA

24.58

121022.9

EPS(TTM)

Face Value()

Div & Yield %

60.97

1.07

Back

Novartis India Ltd - The Board Has Approved The Re-Appointment Of Mr. Sanker Parameswaran (DIN:- 00008187) As An Independent Director For Second (02Nd) Term Of Five (5) Years Subject To The Approval Of The Members.

May 10,2025

The Board has approved the Re-appointment of Mr. Sanker Parameswaran (DIN:- 00008187) as an Independent Director for second(02nd) term of five (5) years subject to the approval of the members.

25,044.35 72.45 (0.29%)

82,055.11 158.32 ( 0.19%)

56,461.90 402.55 ( 0.72%)

38,417.95 3.85 ( 0.01%)

42,601.30 373.47 (0.88%)

6,045.90 57.06 (0.95%)

38,777.68 423.59 (1.10%)

8,758.04 -16.61 (-0.19%)

86.50 -0.18 (-0.20%)

99.61 0.16 (0.17%)

116.27 -0.12 (-0.11%)

0.59 0.00 (-0.73%)